Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabaletta in Machado-Joseph Disease
NCT02147886Phase 2Completed
- Sponsor
- Bioblast Pharma Ltd.
- Start
- Jul 2014
- Primary completion
- Oct 2016
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of trehalose in machado-joseph disease (MJD), sponsored by Bioblast Pharma Ltd.. Started Jul 2014; status: completed.
02
Drugs
trehalose
03
Conditions
machado-joseph disease (MJD)
Beyond the preview
Go deeper on NCT02147886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147886.